NCT06920563

Brief Summary

The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes? Participants will: View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
296

participants targeted

Target at P75+ for not_applicable

Timeline
5mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Mar 2025Oct 2026

Study Start

First participant enrolled

March 17, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

March 25, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 9, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2026

Last Updated

April 9, 2025

Status Verified

April 1, 2025

Enrollment Period

1.6 years

First QC Date

March 25, 2025

Last Update Submit

April 1, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Engagement

    Engagement will be defined by frequency of use: number of remote BP measurements ascertained during the 6 week postpartum period.

    6 weeks

  • Acceptability

    Post program survey questions using 5-item Likert response scale at 6 weeks postpartum

    6 weeks

  • Duration of Participation

    Duration of participation is defined by the last day of recorded remote BP measurement

    6 weeks

Secondary Outcomes (5)

  • Post partum Blood pressure

    1 year

  • Number of ED visits

    1 year

  • Severe Maternal Morbidity

    1 year

  • Number of Inpatient re-admissions

    1 year

  • Post partum visit follow up

    6 weeks

Study Arms (2)

Intervention

EXPERIMENTAL

This group will watch an education video, receive text message updates, and have their blood pressure medications titrated to a lower BP goal.

Other: VideoOther: Text ReminderOther: Blood pressure threshold

Control

NO INTERVENTION

This group will receive usual post partum care from their obstetrician

Interventions

VideoOTHER

Those in the intervention arm will watch a short educational video.

Intervention

Those in the intervention group will receive regular text message reminders to check their blood pressures

Intervention

Those in the intervention group will have a lower blood pressure threshold to titrate their BP medications towards

Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of at least 18 years.
  • Postpartum status.
  • Experience new-onset hypertension during pregnancy.
  • Enrollment in Connected MOM.
  • Ability to provide informed consent.
  • Establish medical care within the Ochsner System to facilitate data collection.

You may not qualify if:

  • History of preeclampsia or gestational hypertension during previous pregnancy
  • History of chronic hypertension
  • History of coronary artery disease (myocardial infarction, coronary stent placement, coronary artery bypass grafting, spontaneous coronary artery dissection)
  • History of ischemic CVA
  • History of Congestive heart failure
  • Renal dysfunction
  • Liver dysfunction
  • Left ventricular dysfunction
  • Congenital heart disease
  • Still birth at delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ochsner Baptist

New Orleans, Louisiana, 70115, United States

RECRUITING

Related Publications (18)

  • Mitro SD, Hedderson M, Xu F, Forquer H, Baker JM, Kuzniewicz MW, Greenberg M. Risk of postpartum readmission after hypertensive disorder of pregnancy and variation by discharge antihypertensive medication prescription. Am J Obstet Gynecol. 2024 Oct;231(4):456.e1-456.e13. doi: 10.1016/j.ajog.2024.01.015. Epub 2024 Jan 25.

    PMID: 38280432BACKGROUND
  • SPRINT Research Group; Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.

    PMID: 26551272BACKGROUND
  • Cairns AE, Tucker KL, Leeson P, Mackillop LH, Santos M, Velardo C, Salvi D, Mort S, Mollison J, Tarassenko L, McManus RJ; SNAP-HT Investigators. Self-Management of Postnatal Hypertension: The SNAP-HT Trial. Hypertension. 2018 Aug;72(2):425-432. doi: 10.1161/HYPERTENSIONAHA.118.10911. Epub 2018 Jul 2.

    PMID: 29967037BACKGROUND
  • Kitt JA, Fox RL, Cairns AE, Mollison J, Burchert HH, Kenworthy Y, McCourt A, Suriano K, Lewandowski AJ, Mackillop L, Tucker KL, McManus RJ, Leeson P. Short-Term Postpartum Blood Pressure Self-Management and Long-Term Blood Pressure Control: A Randomized Controlled Trial. Hypertension. 2021 Aug;78(2):469-479. doi: 10.1161/HYPERTENSIONAHA.120.17101. Epub 2021 Jun 28.

    PMID: 34176288BACKGROUND
  • Hauspurg A, Lemon LS, Quinn BA, Binstock A, Larkin J, Beigi RH, Watson AR, Simhan HN. A Postpartum Remote Hypertension Monitoring Protocol Implemented at the Hospital Level. Obstet Gynecol. 2019 Oct;134(4):685-691. doi: 10.1097/AOG.0000000000003479.

    PMID: 31503166BACKGROUND
  • Mujic E, Parker SE, Nelson KP, O'Brien M, Chestnut IA, Abrams J, Yarrington CD. Implementation of a Cell-Enabled Remote Blood Pressure Monitoring Program During the Postpartum Period at a Safety-Net Hospital. J Am Heart Assoc. 2024 Jul 2;13(13):e034031. doi: 10.1161/JAHA.123.034031. Epub 2024 Jun 27.

    PMID: 38934890BACKGROUND
  • Bateman BT, Schumacher HC, Bushnell CD, Pile-Spellman J, Simpson LL, Sacco RL, Berman MF. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology. 2006 Aug 8;67(3):424-9. doi: 10.1212/01.wnl.0000228277.84760.a2.

    PMID: 16894102BACKGROUND
  • Jeng JS, Tang SC, Yip PK. Stroke in women of reproductive age: comparison between stroke related and unrelated to pregnancy. J Neurol Sci. 2004 Jun 15;221(1-2):25-9. doi: 10.1016/j.jns.2004.03.006.

    PMID: 15178209BACKGROUND
  • Bushnell C, Chireau M. Preeclampsia and Stroke: Risks during and after Pregnancy. Stroke Res Treat. 2011 Jan 20;2011:858134. doi: 10.4061/2011/858134.

    PMID: 21331165BACKGROUND
  • Benschop L, Duvekot JJ, Versmissen J, van Broekhoven V, Steegers EAP, Roeters van Lennep JE. Blood Pressure Profile 1 Year After Severe Preeclampsia. Hypertension. 2018 Mar;71(3):491-498. doi: 10.1161/HYPERTENSIONAHA.117.10338.

    PMID: 29437895BACKGROUND
  • Honigberg MC, Zekavat SM, Aragam K, Klarin D, Bhatt DL, Scott NS, Peloso GM, Natarajan P. Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy. J Am Coll Cardiol. 2019 Dec 3;74(22):2743-2754. doi: 10.1016/j.jacc.2019.09.052. Epub 2019 Nov 11.

    PMID: 31727424BACKGROUND
  • Haug EB, Horn J, Markovitz AR, Fraser A, Klykken B, Dalen H, Vatten LJ, Romundstad PR, Rich-Edwards JW, Asvold BO. Association of Conventional Cardiovascular Risk Factors With Cardiovascular Disease After Hypertensive Disorders of Pregnancy: Analysis of the Nord-Trondelag Health Study. JAMA Cardiol. 2019 Jul 1;4(7):628-635. doi: 10.1001/jamacardio.2019.1746.

    PMID: 31188397BACKGROUND
  • Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, Zaman A, Fryer AA, Kadam U, Chew-Graham CA, Mamas MA. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2):e003497. doi: 10.1161/CIRCOUTCOMES.116.003497. Epub 2017 Feb 22.

    PMID: 28228456BACKGROUND
  • Fasanya HO, Hsiao CJ, Armstrong-Sylvester KR, Beal SG. A Critical Review on the Use of Race in Understanding Racial Disparities in Preeclampsia. J Appl Lab Med. 2021 Jan 12;6(1):247-256. doi: 10.1093/jalm/jfaa149.

    PMID: 33227139BACKGROUND
  • Ouyang P, Sharma G. The Potential for Pregnancy Heart Teams to Reduce Maternal Mortality in Women With Cardiovascular Disease. J Am Coll Cardiol. 2020 Nov 3;76(18):2114-2116. doi: 10.1016/j.jacc.2020.09.007. No abstract available.

    PMID: 33121719BACKGROUND
  • Gad MM, Elgendy IY, Mahmoud AN, Saad AM, Isogai T, Sande Mathias I, Misbah Rameez R, Chahine J, Jneid H, Kapadia SR. Disparities in Cardiovascular Disease Outcomes Among Pregnant and Post-Partum Women. J Am Heart Assoc. 2021 Jan 5;10(1):e017832. doi: 10.1161/JAHA.120.017832. Epub 2020 Dec 16.

    PMID: 33322915BACKGROUND
  • Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019 Mar 29;124(7):1094-1112. doi: 10.1161/CIRCRESAHA.118.313276.

    PMID: 30920918BACKGROUND
  • Croke L. Gestational Hypertension and Preeclampsia: A Practice Bulletin from ACOG. Am Fam Physician. 2019 Nov 15;100(10):649-650. No abstract available.

    PMID: 31730305BACKGROUND

MeSH Terms

Conditions

Pre-EclampsiaPregnancy ComplicationsHypertension, Pregnancy-Induced

Interventions

Videotape Recording

Condition Hierarchy (Ancestors)

Female Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Tape RecordingAudiovisual AidsEducational TechnologyTechnologyTechnology, Industry, and AgricultureTelevision

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2025

First Posted

April 9, 2025

Study Start

March 17, 2025

Primary Completion (Estimated)

October 16, 2026

Study Completion (Estimated)

October 16, 2026

Last Updated

April 9, 2025

Record last verified: 2025-04

Locations